INSM Q3 2020 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$44M+12.2% YoY

Gross Profit

$33M75.7% margin

Operating Income

-$56M-128.8% margin

Net Income

-$64M-145.9% margin

EPS (Diluted)

$-0.63

QoQ Revenue Growth

+2.7%

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$59M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$841M

Total Liabilities

$484M

Stockholders' Equity

$357M

Cash & Equivalents

$589M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$39M	+12.2%
Gross Profit	$33M	$32M	+1.8%
Operating Income	-$56M	-$56M	+0.5%
Net Income	-$64M	-$61M	-4.9%